CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made. The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 30 PhD students, as well as an experienced support team.
PhD Vacancy: Plant-wide dynamic mathematical modelling and optimisation of integrated continuous pharmaceutical manufacturing processes
PhD Vacancy: Plant-wide dynamic mathematical modelling and optimisation of integrated continuous pharmaceutical manufacturing processes.... more
Automated Synthesis Forum
At TIC, University of Strathclyde.... more
Continuous Flow Reactor Technology for Industrial Applications
Hosted in TIC, University of Strathclyde.... more
Call for Feasibility Studies
Closing date for expression of interests: 16th September 2020
Closing date for applications: 1st October 2020
The EPSRC Future Manufacturing CMAC Research Hub is offering funding to support four Feasibility Studies at TRLs 1 – 4.
The funding is available for novel short-term research studies of advanced manufacturing technologies to complement the current Hub research programme of advanced pharmaceutical manufacturing.
This call seeks to support studies primarily aligned with innovative approaches to digital design and application of advanced measurements.
The call is open to all UK academics eligible to receive EPSRC funding and is the primary mechanism for new academic collaborators to engage with the Hub. Awards are limited to a maximum of £60k at 80% FEC and for a project duration of 6-12 months. This call seeks to stimulate applications from existing groups where there is opportunity to leverage significant existing activity that would lead to an ongoing collaboration following feasibility studies. To facilitate active collaboration a Hub Champion will be assigned to work with each funded proposal..... more
Business Case Insights for Continuous Manufacturing
CMAC and PwC are delighted to share ‘The Business Case Insights for Continuous Manufacturing’. This joint document, with input from industrial partners, seeks to review key considerations for building a successful business case for the industrial adoption of innovative Continuous Manufacturing (CM) technologies..... more
CPI launches the SCOUT project to benefit chemical and biochemical SMEs across Scotland
CPI, an independent technology innovation centre and founding member of the UK Government’s High Value Manufacturing Catapult, has today announced the launch of SCOUT, a project to target a breadth of Scottish SMEs working in the high value chemical and biochemical supply chains. The project will leverage technology within CPI and its partner organisations to accelerate and de-risk the growth of Scottish SMEs – including those underserved and remote – by enabling new partnerships and increased technology adoption.
The SCOUT project, which will run over the next three years, will be led by CPI’s Medicines Manufacturing Innovation Centre and is being launched in collaboration with CMAC Future Manufacturing Research Hub and the Industrial Biotechnology Innovation Centre (IBioIC). It aims to serve Scottish SMEs through a three-pronged approach of innovation clinics (currently planned to start in late 2020), Innovation Integrator assessments and deep technical consultancy. The £882k Scottish Outreach (SCOUT) project is jointly funded by the European Regional Development Fund (managed by Scottish Enterprise) CPI, CMAC and IBioIC..... more